glp-1 receptor agonist brand names Costs Explained: Managing Coverage Challenges GI Adverse Effects of Glucagon-Like
Description
Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS
SURPASS-4 evaluated the safety of tirzepatide in a high cardiovascular risk population with advanced T2DM for a duration of 2 years [14]
These benefits are independent of baseline glycemia and duration of diabetes and only minimally related to their glucose-lowering efficacy (254)
10.1016/S0140-6736(14)60649-8 52 LeeP
That is real, and it should not be dismissed
By influencing both pathways, Mounjaro may provide additional benefits for blood sugar management and appetite control compared to GLP-1 agonists alone
